V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270014194 | 270009816 | 1.75 | 90.2 | Curative (C) | 2016-08-22 | 2016-08-23 | CHLVPP | 02 | N | 270017003 | CHLVPP |
| 270014195 | 270009817 | 1.65 | 75.8 | Adjuvant (A) | 2016-02-05 | 2016-03-06 | Fluorouricil + Folonic Acid (MdG) | 02 | N | 270017008 | FLUOROURACIL |
| 270014196 | 270009817 | 0 | null | Palliative (P) | 2014-01-13 | 2014-02-11 | Fluorouracil + Folinic Acid Weekly | N | Y | 270017008 | FLUOROURACIL |
| 270014197 | 270009818 | 1.72 | 80 | Palliative (P) | 2015-08-04 | 2015-08-12 | Bevacizumab + Oxaliplatin +MdG | N | N | 270017013 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270014198 | 270009820 | null | null | Palliative (P) | null | 2013-05-02 | Cetuximab + Radiotherapy Maint | N | N | 270017014 | CETUXIMAB + RT |
| 270014199 | 270009821 | 1.8 | 100.9 | Curative (C) | 2014-06-14 | 2014-06-19 | null | 02 | N | 270017016 | NOT MATCHED |
| 270014200 | 270009822 | 1.72 | 87.5 | null | null | 2014-09-11 | BLEOMYCIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + GEMCITABINE + VINCRISTINE | N | N | 270017017 | NOT MATCHED |
| 270014201 | 270009824 | 1.7 | null | Palliative (P) | null | 2016-01-10 | FLUOROURACIL | null | null | 270017019 | FLUOROURACIL |
| 270014202 | 270009825 | 1.7 | 82.2 | Disease modification (D) | 2013-02-13 | 2013-03-14 | CHLVPP | 02 | Y | 270017022 | CHLVPP |
| 270014203 | 270009829 | 1.78 | null | null | 2018-08-11 | 2018-09-05 | CAPECITABINE + RT | 2 | N | 270017028 | CAPECITABINE + RT |
| 270014204 | 270009829 | null | null | Disease modification (D) | null | 2014-06-21 | DHAP | N | N | 270017028 | DHAP |
| 270014205 | 270009830 | 1.75 | 76 | Neo-adjuvant (N) | 2013-07-24 | 2013-10-16 | DHAP | 2 | N | 270017039 | DHAP |
| 270014206 | 270009833 | 1.62 | 69 | Not known (9) | 2014-12-29 | 2014-12-29 | FLUOROURACIL | N | N | 270017039 | FLUOROURACIL |
| 270014207 | 270017060 | null | 95.6 | Adjuvant (A) | 2013-06-19 | 2013-06-22 | Fluorouricil + Folonic Acid (MdG) | 02 | N | 270017049 | FLUOROURACIL |
| 270014208 | 270009837 | 1.65 | 103.6 | Curative (C) | 2014-05-26 | 2014-05-31 | CHOP R - 21 days | N | N | 270017051 | CHOP R |
| 270014209 | 270009840 | 1.8 | 67 | Curative (C) | 2015-03-29 | 2015-04-16 | CAPECITABINE + RT | N | Y | 270017053 | CAPECITABINE + RT |
| 270014210 | 270009841 | 1.76 | 66 | Palliative (P) | 2017-03-31 | 2017-09-12 | Capecitabine (14 day) + Irinotecan | 2 | N | 270017055 | CAPECITABINE + IRINOTECAN |
| 270014211 | 270009842 | 1.64 | 159.5 | Adjuvant (A) | 2015-04-13 | 2015-09-01 | FLUOROURACIL | 02 | N | 270017056 | FLUOROURACIL |
| 270014212 | 270009846 | 1.62 | 79.3 | Palliative (P) | 2015-01-04 | 2015-01-26 | BLEOMYCIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + GEMCITABINE + VINCRISTINE | N | Y | 270017059 | NOT MATCHED |
| 270014213 | 270009846 | null | 81.7 | Curative (C) | 2018-06-15 | 2018-06-22 | DHAP | N | N | 270017059 | DHAP |
| 270014214 | 270009854 | 1.69 | 61.7 | Palliative (P) | 2018-05-22 | 2018-09-13 | CHLVPP | N | N | 270017065 | CHLVPP |
| 270014215 | 270009855 | 1.75 | 52.5 | Curative (C) | 2014-10-04 | 2014-10-14 | CHOP R - 21 days | 2 | N | 270017065 | CHOP R |
| 270014216 | 270009856 | 1.76 | 50.3 | Neo-adjuvant (N) | 2014-10-23 | 2014-11-20 | Bevacizumab + Oxaliplatin +MdG | N | N | 270017076 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270014217 | 270009859 | 1.62 | 96 | Adjuvant (A) | 2016-05-13 | 2016-05-14 | Fluorouricil + Folonic Acid (MdG) | 2 | null | 270017085 | FLUOROURACIL |
| 270014218 | 270009860 | null | 78 | Palliative (P) | null | 2018-03-20 | Trifluridine + Tipiracil | null | null | 270017087 | TRIFLURIDINE + TIPIRACIL |
| 270014219 | 270009861 | 1.79 | 82.6 | Curative (C) | 2014-10-31 | 2014-11-05 | GEMCITABINE + IFOSFAMIDE + VINORELBINE | 2 | N | 270017091 | GEMCITABINE + IFOSFAMIDE + VINORELBINE |
| 270014220 | 270009862 | 1.76 | 59 | Adjuvant (A) | 2018-10-14 | 2018-10-21 | CISPLATIN + GEMCITABINE | N | null | 270017094 | BEVACIZUMAB |
| 270014221 | 270014614 | 1.64 | 63.2 | Adjuvant (A) | 2015-01-12 | 2015-01-12 | Irinotecan | N | N | 270017100 | IRINOTECAN |
| 270014222 | 270014615 | 1.66 | 26.3 | Not known (9) | 2015-09-12 | 2015-09-16 | Carboplatin AUC 2 - 5 | N | N | 270017102 | NIVOLUMAB |
| 270014223 | 270009866 | 1.73 | 91.1 | Adjuvant (A) | 2015-04-04 | 2015-04-04 | Irinotecan 14day | N | Y | 270017104 | IRINOTECAN |
| 270014224 | 270017066 | 1.69 | 72.6 | Palliative (P) | 2015-05-28 | 2015-05-30 | Irinotecan | 2 | N | 270017112 | IRINOTECAN |
| 270014225 | 270009867 | 1.86 | 58.6 | Curative (C) | 2015-07-19 | 2015-07-22 | Vinblastine | N | N | 270017112 | GEMCITABINE + IFOSFAMIDE + VINORELBINE |
| 270014226 | 270009868 | 1.76 | 55 | Adjuvant (A) | 2018-06-03 | 2018-06-03 | CARBOPLATIN | N | N | 270017117 | VINBLASTINE |
| 270014227 | 270009874 | null | 87.5 | Not known (9) | 2017-01-26 | 2017-05-11 | Cisplatin | N | N | 270017120 | CETUXIMAB + OXALIPLATIN + MDG |
| 270014228 | 270014620 | 1.8 | null | Adjuvant (A) | 2015-08-21 | 2015-09-21 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 270017120 | GEMCITABINE |
| 270014229 | 270009878 | 1.79 | 85.7 | null | 2014-11-14 | 2016-04-01 | IVE | N | N | 270017136 | IVE |
| 270014230 | 270009880 | 1.8 | 104 | Palliative (P) | 2013-12-16 | 2013-12-20 | Bevacizumab 5mg/kg | N | N | 270017140 | PANITUMUMAB |
| 270014231 | 270009881 | 1.88 | 56.75 | Adjuvant (A) | null | 2017-11-08 | Cyclophosphamide High Dose | N | null | 270017149 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 270014232 | 270009882 | 1.63 | null | Curative (C) | 2016-11-13 | 2016-11-13 | BEAM + Alemtuzumab Allo SCT | 02 | N | 270017162 | OXALIPLATIN + RALTITREXED |
| 270014233 | 270009882 | 1.82 | 61.9 | Adjuvant (A) | 2014-06-17 | 2014-06-19 | Bevacizumab 7.5mg/kg | N | N | 270017162 | OXALIPLATIN + RALTITREXED |
| 270014234 | 270009884 | 1.66 | 63 | Disease modification (D) | 2014-05-27 | 2015-04-05 | Cisplatin | N | N | 270017167 | VINBLASTINE |
| 270014235 | 270014622 | 1.72 | 73.2 | Adjuvant (A) | 2018-11-07 | 2018-11-07 | Vinblastine | 02 | N | 270017167 | PANITUMUMAB |
| 270014236 | 270009885 | 1.54 | 72 | Not known (9) | 2017-05-19 | 2017-08-31 | GEMCITABINE | N | N | 270017169 | BEAM + ALEMTUZUMAB |
| 270014237 | 270014624 | 1.55 | 68.8 | Adjuvant (A) | 2015-11-21 | 2015-11-22 | Cetuximab + Oxaliplatin + MdG Maint | 02 | N | 270017175 | GEMCITABINE |
| 270014238 | 270014624 | null | null | Adjuvant (A) | 2014-08-08 | 2014-08-14 | Carboplatin AUC 2 - 5 | N | N | 270017175 | PANITUMUMAB |
| 270014239 | 270019256 | null | 62 | Adjuvant (A) | null | 2013-09-17 | GDP | N | N | 270017182 | GDP |
| 270014240 | 270009889 | 1.61 | null | Neo-adjuvant (N) | 2015-02-28 | 2015-02-28 | Panitumumab | 2 | null | 270017187 | BEAM + ALEMTUZUMAB |
| 270014241 | 270014626 | 1.71 | null | Adjuvant (A) | 2015-05-29 | 2015-05-29 | Panitumumab | 02 | Y | 270017195 | VINBLASTINE |
| 270014242 | 270009891 | 1.65 | 76 | null | 2017-01-30 | 2017-01-30 | CISPLATIN + GEMCITABINE | 02 | N | 270017195 | CISPLATIN |
| 270014243 | 270009891 | 1.89 | 83 | Not known (9) | 2016-05-17 | 2016-05-17 | Bevacizumab 5mg/kg | 02 | N | 270017195 | CISPLATIN |